Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial - Quiz - MDSpire

Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial

  • By

  • Java Walladbegi

  • Roger Henriksson

  • Björn Tavelin

  • Anncarin Svanberg

  • Gunnar Larfors

  • Martin Jädersten

  • Fredrik Schjesvold

  • Aram Mahdi

  • Karin Garming Legert

  • Douglas E. Peterson

  • Mats Jontell

  • November 3, 2021

  • 0 min

Share

Original Source(s)

Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial

  • by Java Walladbegi, Roger Henriksson, Björn Tavelin, Anncarin Svanberg, Gunnar Larfors, Martin Jädersten, Fredrik Schjesvold, Aram Mahdi, Karin Garming Legert, Douglas E. Peterson, Mats Jontell

  • November 3, 2021

Related Content

Case Report: Cytoreductive surgery as a therapeutic attempt in the treatment of extramedullary plasmacytoma

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.

Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholders